Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Resources>Webcasts

  Webcasts

Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.

New Insights in Cell Cultures Continuous Monitoring by Nano-Bio-Technology for Sensing and Imaging
Sandro Carrara, University of Genoa, speaking at Cell Culture 2012

Contactless Impedance Analysis for Real-Time Cell Monitoring
Tim Cox, Research Director, Institute of Bio-sensing Technology, speaking at Advances in Biodetection and Biosensors 2012.

Defence and Adaptation in Drug-Mediated Liver Toxicity
Christopher Goldring, University of Liverpool, speaking at ADME & Predictive Toxicology Europe 2012

Rationalizing ADME in the Current Regulatory and Business Environment
Robert Guttendorf, Aclairo Pharmaceutical Development Group, speaking at ADME & Predictive Toxicology Europe

Metabolites and Safety, the MIST and ICH-M3 GUIDANCE and their Impact on ADME
Gerhard Gross, Lundbeck Pharma, speaking at ADME & Predictive Toxicology Europe 2012

In Vitro, Ex Vivo and in Models to Develop New Therapies for Renal Diseases
Frederick W. K. Tam, Imperial College London, speaking at ADME & Predictive Toxicology Europe 2012

Biotransformation: Still a Bottleneck for in Vitro Kinetic and Dynamic Approaches
Sandra Coecke, European Centre for the Validation of Alternative Methods, speaking at ADME & Predictive Toxicology Europe

In Silico Toxicology: Where are We at and Where are We Going?
John C. Dearden, Liverpool John Moores University, speaking at ADME & Predictive Toxicology Europe 2012

When is a Genotoxin not a Genotoxin?
Richard Walmsley, University of Manchester, speaking at ADME & Predictive Toxicology Europe

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 106
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters